Journal
FRONTIERS IN ONCOLOGY
Volume 12, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2022.1009247
Keywords
molecular mimicry; cross-reacting T cells; anti-cancer immune response; cancer vaccine; microbiota; virus; tumor antigen
Categories
Funding
- Italian Ministry of Health through Institutional Ricerca Corrente
- POR FESR 2014/2020 Campania OncoTerapie
- POR FESR 2014/2020 NanoCAN
Ask authors/readers for more resources
Individuals are exposed to intracellular pathogens and intestinal microbiota, which can induce autoimmune reactions and potentially lead to autoimmune diseases. Recently, it has been found that self-antigens similar to tumor-associated antigens may exist in cancer cells. Selecting non-self antigens with high homology to tumor-associated antigens could greatly improve the efficacy of cancer vaccines.
Individuals are exposed to intracellular pathogens (i.e. viruses and intracellular bacteria) and intestinal microbiota, collectively microorganisms (MOs), which enter the body during the host's lifetime. Altogether, MOs are a natural source of non-self antigens (MoAs) expressed by host's cells in the context of the HLA class I molecules, inducing a wide pool of specific memory CD8(+) T cell clones. Such MoAs have been shown in selected cases to share sequence and structural homology with cellular self-antigens (molecular mimicry), possibly inducing autoimmune reactions leading to autoimmune diseases (ADs). We have recently shown that a molecular mimicry may be found also to self-antigens presented by cancer cells (i.e. tumor-associated antigens, TAAs). Consequently, memory CD8(+) T cell clones specific for the MoAs may turn out to be a natural anti-cancer vaccination if a nascent tumor lesion should express TAAs similar or identical to MoAs. We postulate that selecting MoAs with high homology to TAAs would greatly improve the efficacy of cancer vaccines in both preventive and therapeutic settings. Indeed, non-self MoAs are potently immunogenic because not affected by central immune tolerance. Unravelling the impact of the antigenic molecular mimicry between MoAs and TAAs might pave the way for novel anti-cancer immunotherapies with unprecedented efficacy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available